Latest Announcement

Compremium Corp. Receives FDA clearance for the CPMX1 System

Switzerland based Compremium Corp. announces U.S. Food and Drug Administration FDA510k market clearance of its Compartmental Compressibility Monitoring System CPMX1.
Read
Compremium Corp. Receives FDA clearance for the CPMX1 System
Read
Who is Compremium?

We are a Swiss medical device company focused on solving important unmet needs in the practice of medicine.

1

Passion

Our founder, Dr. med. U. Baumann, has spent more than 20 years perfecting our technology.

2

Precision

We are physicians, engineers, and business professionals driven by the promise of solving unmet needs in healthcare.

3

Purpose

We are singularly committed to improving diagnostics and patient care.

Meet the Team

Vincent Baumann
Chief executive officer
Vincent Baumann

Healthcare leader with 20 years of experience

Linkedin
Ulrich Baumann, MD
Chief Medical Officer
Ulrich Baumann, MD

Passionate medical doctor for 40+ years

Linkedin
Francois Monory
OPEX-Advisor & Board Member
Francois Monory

Global leader & expert in medical device manufacturing and operations; 20+ years of experience with the No. 1 medical device manufacturer

Linkedin
Aswin Bhuvanendran
Chief Commercial Officer
Aswin Bhuvanendran

Commercial leader in life sciences for 15+ years

Linkedin
Patrick Roth
Chief Operations Officer
Patrick Roth

25 years in MedTech and other industries

Linkedin
Peter Frei, MBE
Chief Technology Officer
Peter Frei, MBE

Unique combination of technical and IP know-how for 30 years

Linkedin
Karin Roth
Communication
Karin Roth

Broad experience in scientific and MedTech communication

Linkedin
Cordelia Trümpy
Marketing & Communication
Cordelia Trümpy

Linkedin
André Steiner
Head of Sales
André Steiner

26 years in global MedTech sales organisations

Linkedin
Federico Milani
Head of Software Development
Federico Milani

Software engineer with 4+ years of specialized expertise in Artificial Intelligence and Computer Vision

Linkedin
Charlotte Moerman
Clinical Affairs Manager
Charlotte Moerman

EPFL bioengineering & PhD in Neuroscience specialized in applied research and novel medical devices.

Linkedin
Yan Pellouchoud
Supply Manager
Yan Pellouchoud

Expercienced and creative Supply Management Leader in MedTech for more than 20 years.

Linkedin
Jurjen Zoethout
Regulatory Advisor
Jurjen Zoethout

Business-oriented analytical and strategic thinker with 20+ years of international medical device project team management, R&D, quality, regulatory and clinical expertise.

Linkedin
Markus Savli
Scientific Advisor
Markus Savli

Biostatistician, epidemiologist and data scientist with more than 15 years of clinical trial experience.

Linkedin
Luciana Burdman
Scientific Advisor
Luciana Burdman

High performance and determined scientist and biostatistician with over eight years of experience in life sciences, clinical research and project management.

Linkedin

Compremium’s History

How we got to today.

February 2024

CPMX1 is now MIL-STD 810H compliant and ready for duty! MIL-STD-810H is a military standard developed by the U.S. Department of Defense to test the resistance of equipment to environmental conditions.

APRIL 2023

Compremium receives FDA clearance for the CPMX1 System.

MARCH 2023

Clinical partnership established with Charité - Universitätsmedizin Berlin.

November 2022

FDA clearance study conducted at the University Hospital, Inselspital in Bern by Dr. med. Beat Lehmann, Deputy Chief Physician and Head of the Emergency Department and his team.

JULY 2022

The first Compremium Compressibility Forum takes place at the PostFinance Arena in Bern.

MAY 2022

Andrea Rytz, CEO of the Schulthess Klinik in Zurich initiates the scientific collaboration with Compremium.

2021

Scientific collaboration starts with Maxima Medisch Center and Dr. med. Marc Scheltinga in Veldhoven, Netherlands.

2020

Compremium AG is founded in Muri b. Bern, Switzerland.

2019

Three studies on the use of the VeinPress method on elevated compartment pressure of the leg are published.
NASA publishes the study on the Assessment of Jugular Venous Blood Flow Stasis and Thrombosis During Spaceflight.

2016

NASA initiates a series of scientific tests in space on the International Space Station. Other medical applications are explored by various independent research groups.

2015

PD Dr. med. Richard M. Sellei, Chief Physician of the Department of Orthopaedic and Trauma Surgery at Sana Klinikum Offenbach, publishes first study on the method of measuring compartment elasticity using pressure related ultrasound to identify patients with potential compartment syndrome.

2015

The Compremium method takes flight - NASA starts first tests on the ground in their research labs at Houston, TX and in Cologne, Germany. The tests were followed by intensive testing in parabolic flights with NASA crew members out of Bordeaux, France.

2014

VeinPress wins the prestigious Swiss Medtech Award together with its scientific partners ETH Zurich and the University Hospital Basel.

2013

The VeinPress prototype is further developed in collaboration with ETH Zurich and the University Hospital of Basel.

2012

First scientific results are published by various research groups in renowned scientific journals. Publications have been issued by the university hospitals in Basel, Zurich and Bern, among others.

January 2011

VeinPress Ltd. is founded in Münsingen, Switzerland.

pre-2011

Dr. med. Ulrich Baumann develops the concept of measuring the venous pressure non-invasively. Initial feasibility tests show very promizing results.

Available Positions

Contact careers@compremium.ch for inquiries
Director
Clinical Business Development
Director or Senior Director at Compremium will drive clinical evidence and tech adoption across US hospitals, engaging with healthcare leaders and administrators.